- Home
- PAGS vs KNSA Comparison
PAGS vs KNSA Comparison
Compare PAGS & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAGS | KNSA |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Brazil | United Kingdom |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PAGS | KNSA |
|---|---|---|
| Price | $10.55 | $44.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $11.86 | ★ $55.29 |
| AVG Volume (30 Days) | ★ 3.9M | 509.5K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 1.32% | N/A |
| EPS Growth | N/A | ★ 225.00 |
| EPS | N/A | ★ 0.75 |
| Revenue | N/A | ★ $677,564,000.00 |
| Revenue This Year | $14.75 | $35.71 |
| Revenue Next Year | $5.68 | $17.13 |
| P/E Ratio | ★ $7.74 | $58.23 |
| Revenue Growth | N/A | ★ 60.09 |
| 52 Week Low | $6.70 | $18.26 |
| 52 Week High | $12.32 | $49.12 |
Technical Indicators
Market Signals| Indicator | PAGS | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 50.82 |
| Support Level | $9.89 | $41.98 |
| Resistance Level | $11.19 | $45.50 |
| Average True Range (ATR) | 0.52 | 1.98 |
| MACD | -0.07 | -0.30 |
| Stochastic Oscillator | 34.47 | 39.81 |
Price Performance
Historical ComparisonAbout PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.